Does TOFACITINIB Cause Finger deformity? 707 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 707 reports of Finger deformity have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.5% of all adverse event reports for TOFACITINIB.
707
Reports of Finger deformity with TOFACITINIB
0.5%
of all TOFACITINIB reports
277
Deaths
351
Hospitalizations
How Dangerous Is Finger deformity From TOFACITINIB?
Of the 707 reports, 277 (39.2%) resulted in death, 351 (49.6%) required hospitalization, and 270 (38.2%) were considered life-threatening.
Is Finger deformity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 707 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Finger deformity?
ETANERCEPT (1,293)
ADALIMUMAB (1,260)
METHOTREXATE (1,003)
LEFLUNOMIDE (798)
RITUXIMAB (731)
ABATACEPT (663)
TOCILIZUMAB (622)
SECUKINUMAB (606)
HYDROXYCHLOROQUINE (550)
SULFASALAZINE (531)
Which TOFACITINIB Alternatives Have Lower Finger deformity Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN